Referenties

  1. ATS/ERS_Am J Respir Crit Care Med Vol 168;2003:818–900
  2. Miravitlles M et al Eur.Resp.J.2017(50):1-23
  3. Kueppers F et al. All.Ast.Proc 2017(38)108-114
  4. Brebner J.A. Expert Rev. Respir. 2013- 7(3):213-230
  5. Stockley R.A. et al ClinChestMed 2014(35):39-50
  6. Stoller J.K. Am J Resp and Crit Care Med 2012(185):246-259
  7. Teschler H. Eur.Res.Rev2015(24):46-51
  8. Stolk J. et al. J. of rare diseases 2008(3)16:1-9
  9. Monhanka M. Exp.Opin.Biol.Ther. 2012 12(6):685-700
  10. Petrache I. Bio.Tar&Ther.2009(3)193-204
  11. Chotirmall Ther. And Clinc Risc Man. 2015(11):143-151
  12. Silverman E. N.Eng.Med 2009:360(26):2749-2757
  13. Prestatie- en tariefbeschikking add-on humaan Alfa1-Proteinaseremmer NZA, 1 december 2016